Analysts positive on Aurobindo Pharma

Following a higher growth guidance and better margin outlook, brokerages Edelweiss Securities and Angel Broking have turned positive on the Aurobindo Pharma scrip. They have recommended their clients to its shares as they expect the firm’s revenue to expand in coming quarters following USFDA nod for its products.